Clinical Trials on Hyperphagia in Australia

Total 38 results

Singapore General Hospital

Recruiting

A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula (PREDATOR)

Dialysis Access Malfunction | Neointimal Hyperplasia

Singapore, Australia
RDC Clinical Pty Ltd

Recruiting

Comparison of 2 Extracts of Saw Palmetto Versus Placebo on BPH Symptoms

Benign Prostatic Hyperplasia

Australia
ProVerum Medical

Completed

The ProVerum First in Man PROVE Study

Benign Prostatic Hyperplasia

Australia
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United Kingdom, Taiwan, Korea, Republic of, Canada, Slovakia, France, Italy, Austria, Czech Republic, Australia, Germany
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

Italy, France, Belgium, Australia, Greece, Austria, Netherlands, Germany, Mexico, Poland
Zenflow, Inc.

Recruiting

The Zenflow Spring System EU Safety and Performance Study (ZEST EU)

Benign Prostatic Hyperplasia

Australia, New Zealand
Light Sciences Oncology

Completed

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

New Zealand, Australia
Medical University of Vienna

Unknown

Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions (BIOFLEX-COF)

Stent Restenosis | Intimal Hyperplasia

Austria
MedeonBio, Inc.

Active, not recruiting

Safety and Feasibility of the XFLO Expander System (Mercury) (EXPANDER-1)

Benign Prostatic Hyperplasia

Taiwan, Canada, Australia, Georgia
Medical University of Vienna

Completed

Women With Asymptomatic Endometrial Hyperplasia (FAME-ENDO)

Endometrial Hyperplasia

Austria
Krankenhaus Barmherzige Schwestern Linz

Completed

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Endometrial Cancer | Atypical Hyperplasia

Austria
International Biomedical Systems S.p.A.
CSC Pharmaceuticals

Unknown

Numen Stent Assessment Using OCT Technique in a Single Center Study (NAUTIC)

Hyperplasia | Restenosis

Austria
Resurge Therapeutics Inc.

Recruiting

RT-310 Dose Escalation BPH Study

Lower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)

New Zealand, Australia
Salzburger Landeskliniken

Unknown

Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate

Benign Prostatic Hyperplasia | Bladder Outlet Obstruction

Austria, Switzerland
Eli Lilly and Company

Completed

A Study in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Italy, Austria
Queensland Centre for Gynaecological Cancer
The University of Queensland; Queensland University of Technology

Active, not recruiting

Improving the Treatment for Women With Early Stage Cancer of the Uterus (feMMe)

Complex Endometrial Hyperplasia With Atypia | Grade 1 Endometrial Endometrioid Adenocarcinoma

Australia, New Zealand
Medical University of Vienna
National Bank of Austria

Completed

Randomised Controlled Study on the Use of Psychoeducation for Bulimia Nervosa in Young Women

Bulimia Nervosa

Austria
Shire

Completed

Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder

Binge-eating Disorder

Australia
Boston Scientific Corporation

Recruiting

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men (VAPEUR RCT)

Benign Prostatic Hyperplasia (BPH)

France, Australia
Eli Lilly and Company

Terminated

A Study in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
NeoTract, Inc.

Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)

Benign Prostatic Hyperplasia

United States, Australia, Canada
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) (WATER)

Benign Prostatic Hyperplasia (BPH)

United States, Australia, United Kingdom, New Zealand
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
Boston Scientific Corporation

Completed

Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH

Benign Prostatic Hyperplasia

United Kingdom, Germany, Austria, Spain, Belgium, France, Italy, Netherlands, Switzerland
Sophiris Bio Corp

Completed

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (PLUS-1)

Benign Prostatic Hyperplasia

United States, Australia, Canada, Russian Federation, Ukraine, New Zealand
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH); University of Aarhus; University... and other collaborators

Completed

Eating Disorders Genetics Initiative (EDGI)

Anorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa

United States, Australia, New Zealand
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
Pfizer

Completed

Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.

Prostatic Hyperplasia

Australia, Denmark, Spain, Colombia, Slovakia, Chile, Canada, Finland, Italy, Poland, Greece, Belgium, United Kingdom, Latvia, Lithuania
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Spruce Biosciences

Active, not recruiting

A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

Congenital Adrenal Hyperplasia

United States, Australia, Brazil, Canada, Denmark, Estonia, Germany, Ireland, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
Astellas Pharma Inc

Completed

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

France, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
Spruce Biosciences

Active, not recruiting

A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH

Congenital Adrenal Hyperplasia

United States, Australia, Brazil, Estonia, Germany, Korea, Republic of, Latvia, Lithuania, Poland, Romania, Spain, Sweden, Turkey, Canada, Italy, United Kingdom
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel
Neurocrine Biosciences

Active, not recruiting

Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtalyst)

Congenital Adrenal Hyperplasia

United States, Spain, Belgium, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Serbia, Sweden, United Kingdom
Millendo Therapeutics SAS

Terminated

Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome (ZEPHYR)

Hyperphagia | Prader-Willi Syndrome

United States, Belgium, Spain, France, Italy, United Kingdom, Australia, Netherlands

Clinical Trials on Hyperphagia in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations